B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference58 articles.
1. B-cell targeting in rheumatoid arthritis and other autoimmune diseases
2. Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy
3. Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?
4. Role of Rituximab Therapy in Glomerulonephritis: Table 1.
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Successful long-term systemic sclerosis treatment by high-frequent low-dose B cell-depleting therapy;Journal of Autoimmunity;2024-07
2. State of the art: the treatment of systemic lupus erythematosus;Current Opinion in Allergy & Clinical Immunology;2024-05-20
3. A new perspective on therapies involving B-cell depletion in autoimmune diseases;Molecular Biology Reports;2024-05-08
4. Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?;Clinical and Experimental Immunology;2024-04-20
5. Outcomes with the use of rituximab in patients with refractory lupus nephritis in a Colombian cohort;Revista Colombiana de Reumatología (English Edition);2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3